Publicaciones (81) Publicaciones en las que ha participado algún/a investigador/a

2004

  1. Behavioral and molecular changes elicited by acute administration of SR141716 to Δ 9 -tetrahydrocannabinol-tolerant rats: An experimental model of cannabinoid abstinence

    Drug and Alcohol Dependence, Vol. 74, Núm. 2, pp. 159-170

  2. Serotonin 5-HT 7 receptor antagonists

    Current Medicinal Chemistry - Central Nervous System Agents, Vol. 4, Núm. 3, pp. 203-214

  3. 3,4-Methylenedioxymethamphetamine increases interleukin-1β levels and activates microglia in rat brain: Studies on the relationship with acute hyperthermia and 5-HT depletion

    Journal of Neurochemistry, Vol. 89, Núm. 6, pp. 1445-1453

  4. 4,5-Dihydro-1H-pyrazole derivatives with inhibitory nNOS activity in rat brain: Synthesis and structure - Activity relationships

    Journal of Medicinal Chemistry, Vol. 47, Núm. 23, pp. 5641-5650

  5. A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response

    European Journal of Pharmacology, Vol. 500, Núm. 1-3 SPEC. ISS., pp. 3-13

  6. Activity of inducible and neuronal nitric oxide synthases in colonic mucosa predicts progression of ulcerative colitis

    American Journal of Gastroenterology, Vol. 99, Núm. 9, pp. 1756-1764

  7. Acute and long-term of MDMA on cerebral dopamine biochemistry and function

    Psychopharmacology, Vol. 173, Núm. 3-4, pp. 249-263

  8. Adenosine Tetraphosphate, Ap4, a Physiological Regulator of Intraocular Pressure in Normotensive Rabbit Eyes

    Journal of Pharmacology and Experimental Therapeutics, Vol. 308, Núm. 2, pp. 468-473

  9. Análisis del riesgo de los medicamentos veterinarios presentes en los alimentos

    Actualidad en farmacología y terapéutica, Vol. 2, Núm. 3, pp. 168-175

  10. Aspectos moleculares de la interacción de los fármacos con sus dianas farmacológicas

    Velázquez. Farmacología Básica y Clínica (Editorial Médica Panamericana S.A.), pp. 71-95

  11. Benzimidazole derivatives. Part 5: Design and synthesis of new benzimidazole-arylpiperazine derivatives acting as mixed 5-HT 1A/5-HT 3 ligands

    Bioorganic and Medicinal Chemistry, Vol. 12, Núm. 19, pp. 5181-5191

  12. Brain oxidative markers in stress: Posible new drug targets against neuroinflammation

    Current Neuropharmacology, Vol. 2, Núm. 2, pp. 183-189

  13. Cannabinoids and gene expression during brain development

    Neurotoxicity Research, Vol. 6, Núm. 5, pp. 389-401

  14. Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas

    Cancer Research, Vol. 64, Núm. 16, pp. 5617-5623

  15. Ceramide sensitizes astrocytes to oxidative stress: Protective role of cannabinoids

    Biochemical Journal, Vol. 380, Núm. 2, pp. 435-440

  16. Changes in endocannabinoid contents in reward-related brain regions of alcohol-exposed rats, and their possible relevance to alcohol relapse

    British Journal of Pharmacology, Vol. 143, Núm. 4, pp. 455-464

  17. Characterization of an anandamide degradation system in prostate epithelial PC-3 cells: Synthesis of new transporter inhibitors as tools for this study

    British Journal of Pharmacology, Vol. 141, Núm. 3, pp. 457-467

  18. Comparison of anandamide transport in FAAH wild-type and knockout neurons: Evidence for contributions by both FAAH and the CB1 receptor to anandamide uptake

    Biochemistry, Vol. 43, Núm. 25, pp. 8184-8190

  19. DRD2 TaqIA polymorphism is associated with urinary homovanillic acid levels in a sample of Spanish male alcoholic patients

    Neurotoxicity Research, Vol. 6, Núm. 5, pp. 373-377

  20. Down-regulation of the AMPA glutamate receptor subunits GluR1 and GluR2/3 in the rat cerebellum following pre- and perinatal Δ9- tetrahydrocannabinol exposure

    Cerebellum, Vol. 3, Núm. 2, pp. 66-74